Balancing the scale: the role of oral anticoagulants in atrial fibrillation

Atrial fibrillation is the most common recurrent arrhythmia worldwide, and can put patients at increased risk of stroke.

Report any CAM adverse effects, warns Dr Geraldine Moses

Doctor of clinical pharmacy, consultant pharmacist and pharmacovigilance expert Geraldine Moses discusses the scary adverse effects of CAM.

TGA approves Pfizer booster for teens

Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.

Pharmacists scramble to protect remote communities from COVID-19

Clusters of infection in regional and remote areas continue to grow, with overworked pharmacists adapting their services to minimise the spread.

How GP pharmacist medicine reviews prevent hospital readmissions

When under the care of a general practice pharmacist, patients recently discharged from hospital are far less likely to re-present, according to new research.

Expect an increase in demand for long-acting injectable buprenorphine

Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.